<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Novartis Pharmaceuticals Corporation v. Biocon Pharma Limited et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2022cv00726/79090</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2022cv00726/79090/feed" rel="self" type="application/rss+xml" />
        <pubDate>Fri, 26 Jun 2026 03:43:00 -0700</pubDate>
        <lastBuildDate>Fri, 26 Jun 2026 03:43:00 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Novartis Pharmaceuticals Corporation v. Biocon Pharma Limited et al - Docket Entries - Showing 1 through 7</description>
                                    <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiff's Initial Infringement Chart for U.S. Patent No. 11,058,667 and Plaintiff's First Supplemental Infringement Chart for U.S. Patent No. 11,096,918 against Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250095</guid>
                <pubDate>
            Mon, 25 Jul 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Nicholas N. Kallas and Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250094</guid>
                <pubDate>
            Tue, 14 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Jared L. Stringham for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250093</guid>
                <pubDate>
            Thu, 09 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Christopher E. Loh for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250092</guid>
                <pubDate>
            Thu, 09 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham)(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250090</guid>
                <pubDate>
            Wed, 08 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250089</guid>
                <pubDate>
            Wed, 08 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #6 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham, filed by Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 6/8/2022. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17250091</guid>
                <pubDate>
            Wed, 08 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542248</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,667. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542247</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/18/2022. Date of Expiration of Patent: 5/9/2036.Thirty Month Stay Deadline: 7/7/2023. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542246</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542245</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-3887457.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542244</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                No Summons Issued. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_16542249</guid>
                <pubDate>
            Thu, 02 Jun 2022 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
